GMRE Global Medical REIT Inc.
CATEGORY BREAKDOWN
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
> 50% strong
Gross Margin
Revenue retained after direct costs
> 50% strong
Cash Runway
Months of cash at current burn rate
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
< 25% strong
Price / Sales
Market cap relative to trailing revenue
< 3x strong
Rule of 40
Growth rate plus operating margin
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
< 5% ideal
5 more metrics available
Unlock all 8 metrics, score history, watchlist, and side-by-side comparison.
Try Free for 30 DaysAI ANALYSIS REPORT
AI-GENERATEDBUSINESS SUMMARY
Global Medical REIT Inc. (GMRE) is a real estate company trading on NYQ with a market capitalization of $980M. The company currently carries a SPECULATIVE rating of 60/100, suggesting a mixed fundamental profile with both strengths and weaknesses. The fundamental profile shows modest single-digit revenue growth at 6.7% year-over-year, paired with strong gross margins well above industry average at 77.9%. The balance sheet shows high leverage that significantly increases financial risk, and the company has effectively infinite cash runway, indicating operational self-sufficiency.
VERDICT
GMRE scores 60/100 — a mixed profile with some promising metrics alongside notable weaknesses. This is a higher-risk, higher-reward proposition that depends heavily on execution. This report is based on the latest available financial data and is intended as a starting point for research, not a buy or sell recommendation.
MARKET OPPORTUNITY
In real estate, debt levels and cash flow generation are primary concerns. Growth typically comes from acquisitions and development rather than organic expansion. Global Medical REIT Inc. operates with moderate insider ownership of 6.3%, which provides a signal about management's confidence in the company's direction. At a market cap of $980M, the company is moderately valued on a price-to-sales basis at 6.8x P/S. The combination of these factors positions GMRE as a higher-risk position that requires careful due diligence before considering an investment.
REVENUE QUALITY
Revenue growth stands at 6.7% year-over-year, which is in line with the typical small-cap growth rate. Gross margins of 77.9% are strong and suggest pricing power or an asset-light business model. The Rule of 40 score of 31 falls below the benchmark, suggesting room for improvement in balancing growth and profitability. Cash runway is effectively infinite, meaning the company generates enough cash to sustain operations without external funding.
COMPETITIVE ADVANTAGE
Evaluating Global Medical REIT Inc.'s competitive position requires looking beyond the numbers. Insider ownership at 6.3% is relatively low, which may indicate that management's interests are less aligned with shareholders. The high gross margins suggest some form of competitive moat — whether through proprietary technology, brand value, regulatory barriers, or network effects. Share count management has been reasonable. Investors should research the specific sources of competitive advantage — patents, customer switching costs, scale economies, or brand — that could protect margins over time.
GROWTH THESIS
GMRE presents a speculative fundamental profile that requires a specific thesis to justify investment. The self-funding business model means growth isn't dependent on external capital, reducing dilution risk. Key catalysts to watch include: revenue growth trajectory over the next 2-3 quarters, margin expansion or contraction, and any changes in insider buying or selling activity.
KEY RISKS
The elevated debt-to-equity ratio of 131x increases financial risk and limits the company's flexibility to weather downturns or invest in growth. Small-cap stocks carry inherently higher risk than large-caps, including limited analyst coverage, lower institutional ownership, and higher sensitivity to market downturns. Always conduct thorough due diligence beyond quantitative metrics.
Full AI Report available
Unlock the complete analysis including market opportunity, revenue quality, competitive moat, growth thesis, and risk assessment.
Try Free for 30 DaysReport generated: Mar 26, 2026
SCORE HISTORY
Track how this score changes over time. Start your free trial to see the full score trend chart.
RELATED STOCKS
SCORE ALERT
Get notified when GMRE's score changes by 5+ points.
DATA INFO
Last updated: Mar 11, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.